Generic Injectables Industry Research Report 2023

Report ID
38667
Publisher
Published Date
08-Aug
Delivery Format
PDF
No of Report Page
93
Editor's Rating
US $2,950.00
US $4,425.00
US $5,900.00
  • Report Details
    This report aims to provide a comprehensive presentation of the global market for Generic Injectables, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injectables.
    The Generic Injectables market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Generic Injectables market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
    The report will help the Generic Injectables companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
    Key Companies & Market Share Insights
    In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
        Hospira (Pfizer Inc.)
        Fresenius Kabi
        Sandoz (Novartis)
        Hikma Pharmaceuticals PLC
        Dr. Reddy’s Laboratories Ltd
        Grifols
        Nichi-Iko Group (Sagent)
        Teva Pharmaceutical
        Auromedics
        Sanofi
        Gland Pharma
        Endo International PLC
    Product Type Insights
    Global markets are presented by Generic Injectables type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Generic Injectables are procured by the companies.
    This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
    Generic Injectables segment by Type
        Small Molecule
        Large Molecule
    Application Insights
    This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
    This report also outlines the market trends of each segment and consumer behaviors impacting the Generic Injectables market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Generic Injectables market.
    Generic Injectables Segment by Application
        Oncology
        Anesthesia
        Anti-Infectives
        Parenteral Nutrition
        Cardiovascular Diseases
    Regional Outlook
    This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
    The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
        North America
            United States
            Canada
        Europe
            Germany
            France
            UK
            Italy
            Russia
            Nordic Countries
            Rest of Europe
        Asia-Pacific
            China
            Japan
            South Korea
            Southeast Asia
            India
            Australia
            Rest of Asia
        Latin America
            Mexico
            Brazil
            Rest of Latin America
        Middle East & Africa
            Turkey
            Saudi Arabia
            UAE
            Rest of MEA
    Key Drivers & Barriers
    High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
    COVID-19 and Russia-Ukraine War Influence Analysis
    The readers in the section will understand how the Generic Injectables market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
    Reasons to Buy This Report
    This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
    This report will help stakeholders to understand the global industry status and trends of Generic Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.
    This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
    This report stays updated with novel technology integration, features, and the latest developments in the market
    This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Generic Injectables industry.
    This report helps stakeholders to gain insights into which regions to target globally
    This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Injectables.
    This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
    Core Chapters
    Chapter 1: Research objectives, research methods, data sources, data cross-validation;
    Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
    Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
    Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
    Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
    Chapter 6: Detailed analysis of Generic Injectables companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
    Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
    Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
    Chapter 13: The main points and conclusions of the report.
    
  • Table Of Content
    1 Preface
        1.1 Scope of Report
        1.2 Reasons for Doing This Study
        1.3 Research Methodology
        1.4 Research Process
        1.5 Data Source
            1.5.1 Secondary Sources
            1.5.2 Primary Sources
    2 Market Overview
        2.1 Product Definition
        2.2 Generic Injectables by Type
            2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
            1.2.2 Small Molecule
            1.2.3 Large Molecule
        2.3 Generic Injectables by Application
            2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
            2.3.2 Oncology
            2.3.3 Anesthesia
            2.3.4 Anti-Infectives
            2.3.5 Parenteral Nutrition
            2.3.6 Cardiovascular Diseases
        2.4 Assumptions and Limitations
    3 Generic Injectables Breakdown Data by Type
        3.1 Global Generic Injectables Historic Market Size by Type (2018-2023)
        3.2 Global Generic Injectables Forecasted Market Size by Type (2023-2028)
    4 Generic Injectables Breakdown Data by Application
        4.1 Global Generic Injectables Historic Market Size by Application (2018-2023)
        4.2 Global Generic Injectables Forecasted Market Size by Application (2018-2023)
    5 Global Growth Trends
        5.1 Global Generic Injectables Market Perspective (2018-2029)
        5.2 Global Generic Injectables Growth Trends by Region
            5.2.1 Global Generic Injectables Market Size by Region: 2018 VS 2022 VS 2029
            5.2.2 Generic Injectables Historic Market Size by Region (2018-2023)
            5.2.3 Generic Injectables Forecasted Market Size by Region (2024-2029)
        5.3 Generic Injectables Market Dynamics
            5.3.1 Generic Injectables Industry Trends
            5.3.2 Generic Injectables Market Drivers
            5.3.3 Generic Injectables Market Challenges
            5.3.4 Generic Injectables Market Restraints
    6 Market Competitive Landscape by Players
        6.1 Global Top Generic Injectables Players by Revenue
            6.1.1 Global Top Generic Injectables Players by Revenue (2018-2023)
            6.1.2 Global Generic Injectables Revenue Market Share by Players (2018-2023)
        6.2 Global Generic Injectables Industry Players Ranking, 2021 VS 2022 VS 2023
        6.3 Global Key Players of Generic Injectables Head office and Area Served
        6.4 Global Generic Injectables Players, Product Type & Application
        6.5 Global Generic Injectables Players, Date of Enter into This Industry
        6.6 Global Generic Injectables Market CR5 and HHI
        6.7 Global Players Mergers & Acquisition
    7 North America
        7.1 North America Generic Injectables Market Size (2018-2029)
        7.2 North America Generic Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2029
        7.3 North America Generic Injectables Market Size by Country (2018-2023)
        7.4 North America Generic Injectables Market Size by Country (2024-2029)
        7.5 United States
        7.6 Canada
    8 Europe
        8.1 Europe Generic Injectables Market Size (2018-2029)
        8.2 Europe Generic Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2029
        8.3 Europe Generic Injectables Market Size by Country (2018-2023)
        8.4 Europe Generic Injectables Market Size by Country (2024-2029)
        7.4 Germany
        7.5 France
        7.6 U.K.
        7.7 Italy
        7.8 Russia
        7.9 Nordic Countries
    9 Asia-Pacific
        9.1 Asia-Pacific Generic Injectables Market Size (2018-2029)
        9.2 Asia-Pacific Generic Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2029
        9.3 Asia-Pacific Generic Injectables Market Size by Country (2018-2023)
        9.4 Asia-Pacific Generic Injectables Market Size by Country (2024-2029)
        8.4 China
        8.5 Japan
        8.6 South Korea
        8.7 Southeast Asia
        8.8 India
        8.9 Australia
    10 Latin America
        10.1 Latin America Generic Injectables Market Size (2018-2029)
        10.2 Latin America Generic Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2029
        10.3 Latin America Generic Injectables Market Size by Country (2018-2023)
        10.4 Latin America Generic Injectables Market Size by Country (2024-2029)
        9.4 Mexico
        9.5 Brazil
    11 Middle East & Africa
        11.1 Middle East & Africa Generic Injectables Market Size (2018-2029)
        11.2 Middle East & Africa Generic Injectables Market Growth Rate by Country: 2018 VS 2022 VS 2029
        11.3 Middle East & Africa Generic Injectables Market Size by Country (2018-2023)
        11.4 Middle East & Africa Generic Injectables Market Size by Country (2024-2029)
        10.4 Turkey
        10.5 Saudi Arabia
        10.6 UAE
    12 Players Profiled
        11.1 Hospira (Pfizer Inc.)
            11.1.1 Hospira (Pfizer Inc.) Company Detail
            11.1.2 Hospira (Pfizer Inc.) Business Overview
            11.1.3 Hospira (Pfizer Inc.) Generic Injectables Introduction
            11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2017-2022)
            11.1.5 Hospira (Pfizer Inc.) Recent Development
        11.2 Fresenius Kabi
            11.2.1 Fresenius Kabi Company Detail
            11.2.2 Fresenius Kabi Business Overview
            11.2.3 Fresenius Kabi Generic Injectables Introduction
            11.2.4 Fresenius Kabi Revenue in Generic Injectables Business (2017-2022)
            11.2.5 Fresenius Kabi Recent Development
        11.3 Sandoz (Novartis)
            11.3.1 Sandoz (Novartis) Company Detail
            11.3.2 Sandoz (Novartis) Business Overview
            11.3.3 Sandoz (Novartis) Generic Injectables Introduction
            11.3.4 Sandoz (Novartis) Revenue in Generic Injectables Business (2017-2022)
            11.3.5 Sandoz (Novartis) Recent Development
        11.4 Hikma Pharmaceuticals PLC
            11.4.1 Hikma Pharmaceuticals PLC Company Detail
            11.4.2 Hikma Pharmaceuticals PLC Business Overview
            11.4.3 Hikma Pharmaceuticals PLC Generic Injectables Introduction
            11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2017-2022)
            11.4.5 Hikma Pharmaceuticals PLC Recent Development
        11.5 Dr. Reddy’s Laboratories Ltd
            11.5.1 Dr. Reddy’s Laboratories Ltd Company Detail
            11.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
            11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Introduction
            11.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2017-2022)
            11.5.5 Dr. Reddy’s Laboratories Ltd Recent Development
        11.6 Grifols
            11.6.1 Grifols Company Detail
            11.6.2 Grifols Business Overview
            11.6.3 Grifols Generic Injectables Introduction
            11.6.4 Grifols Revenue in Generic Injectables Business (2017-2022)
            11.6.5 Grifols Recent Development
        11.7 Nichi-Iko Group (Sagent)
            11.7.1 Nichi-Iko Group (Sagent) Company Detail
            11.7.2 Nichi-Iko Group (Sagent) Business Overview
            11.7.3 Nichi-Iko Group (Sagent) Generic Injectables Introduction
            11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2017-2022)
            11.7.5 Nichi-Iko Group (Sagent) Recent Development
        11.8 Teva Pharmaceutical
            11.8.1 Teva Pharmaceutical Company Detail
            11.8.2 Teva Pharmaceutical Business Overview
            11.8.3 Teva Pharmaceutical Generic Injectables Introduction
            11.8.4 Teva Pharmaceutical Revenue in Generic Injectables Business (2017-2022)
            11.8.5 Teva Pharmaceutical Recent Development
        11.9 Auromedics
            11.9.1 Auromedics Company Detail
            11.9.2 Auromedics Business Overview
            11.9.3 Auromedics Generic Injectables Introduction
            11.9.4 Auromedics Revenue in Generic Injectables Business (2017-2022)
            11.9.5 Auromedics Recent Development
        11.10 Sanofi
            11.10.1 Sanofi Company Detail
            11.10.2 Sanofi Business Overview
            11.10.3 Sanofi Generic Injectables Introduction
            11.10.4 Sanofi Revenue in Generic Injectables Business (2017-2022)
            11.10.5 Sanofi Recent Development
        11.11 Gland Pharma
            11.11.1 Gland Pharma Company Detail
            11.11.2 Gland Pharma Business Overview
            11.11.3 Gland Pharma Generic Injectables Introduction
            11.11.4 Gland Pharma Revenue in Generic Injectables Business (2017-2022)
            11.11.5 Gland Pharma Recent Development
        11.12 Endo International PLC
            11.12.1 Endo International PLC Company Detail
            11.12.2 Endo International PLC Business Overview
            11.12.3 Endo International PLC Generic Injectables Introduction
            11.12.4 Endo International PLC Revenue in Generic Injectables Business (2017-2022)
            11.12.5 Endo International PLC Recent Development
    13 Report Conclusion
    14 Disclaimer
    
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
connect with us